Thus, we examined the expression of the molecules involved in the insulin pathway in the endometrium of women with PCOS and found that peroxisome proliferator-activated receptor-γ (PPARγ) was decreased in women with normoweight PCOS compared with controls. Here, PPARG is linked to polycystic ovary syndrome.